Market Value102,762,727
Total Holdings66
File Date2025-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
YMAB / Y-mAbs Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
AYTU / Aytu BioPharma, Inc.
ESPR / Esperion Therapeutics, Inc.
XGN / Exagen Inc.
HRTX / Heron Therapeutics, Inc.
INDV / Indivior PLC
URGN / UroGen Pharma Ltd.
IRWD / Ironwood Pharmaceuticals, Inc.
ADMA / ADMA Biologics, Inc.
AQST / Aquestive Therapeutics, Inc.
XERS / Xeris Biopharma Holdings, Inc.
TELA / TELA Bio, Inc.
IMAB / I-Mab - Depositary Receipt (Common Stock)
MIST / Milestone Pharmaceuticals Inc.
PROF / Profound Medical Corp.
SCPH / scPharmaceuticals Inc.
THRD / Third Harmonic Bio, Inc.
ACET / Adicet Bio, Inc.
KZR / Kezar Life Sciences, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
IOVA / Iovance Biotherapeutics, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
ALIMERA SCIENCES INC CVR / (016CVR029)
RVNC / Revance Therapeutics, Inc.
ALLR / Allarity Therapeutics, Inc.
ELEV / Elevation Oncology, Inc.
TSVT / 2seventy bio, Inc.
JAZZ / Jazz Pharmaceuticals plc
AMARIN CORP PLC / SPONS ADR NEW (023111206)
COLL / Collegium Pharmaceutical, Inc.
PYPD / PolyPid Ltd.
GRCE / Grace Therapeutics, Inc.
AADI / Aadi Bioscience, Inc.
PMVP / PMV Pharmaceuticals, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
OPTN / OptiNose, Inc.
ITOS / iTeos Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
KPRX / Kiora Pharmaceuticals, Inc.
VIR / Vir Biotechnology, Inc.
INO / Inovio Pharmaceuticals, Inc.
EBS / Emergent BioSolutions Inc.
SLRN / Acelyrin, Inc.
SRZN / Surrozen, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
HLVX / HilleVax, Inc.
ACRS / Aclaris Therapeutics, Inc.
BIOA / BioAge Labs, Inc.
XOMA / XOMA Royalty Corporation
EOLS / Evolus, Inc.
VNDA / Vanda Pharmaceuticals Inc.
ZVRA / Zevra Therapeutics, Inc.
IKT / Inhibikase Therapeutics, Inc.
EDSA / Edesa Biotech, Inc.
CALC / CalciMedica, Inc.
KROS / Keros Therapeutics, Inc.
ANTX / AN2 Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
THTX / Theratechnologies Inc.
ANIP / ANI Pharmaceuticals, Inc.
ESTA / Establishment Labs Holdings Inc.
DAWN / Day One Biopharmaceuticals, Inc.
MYO / Myomo, Inc.
VSTM / Verastem, Inc.
SVRA / Savara Inc.
ENTA / Enanta Pharmaceuticals, Inc.
ELAN / Elanco Animal Health Incorporated
GERN / Geron Corporation
ANIK / Anika Therapeutics, Inc.
CRGX / CARGO Therapeutics, Inc.
APRE / Aprea Therapeutics, Inc.
SEPN / Septerna, Inc.
NKTX / Nkarta, Inc.
RNXT / RenovoRx, Inc.